Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 02-Apr-24 6:31 PM View:  | Wagner Paul A. See Remarks Director | Forte Biosciences, Inc. (FBRX) | 01-Apr-24 | Option Exercise | 31,250 | -- | -- | 2% 1.85M to 1.88M | |
| 02-Apr-24 6:32 PM View: | Riley Anthony A Chief Financial Officer | Forte Biosciences, Inc. (FBRX) | 01-Apr-24 | Option Exercise | 9,375 | -- | -- | 5% 188.44K to 197.82K | |
| 02-Apr-24 6:31 PM View: | Wagner Paul A. See Remarks Director | Forte Biosciences, Inc. (FBRX) | 01-Apr-24 | Payment of Exercise | 2,453 | $0.71 | $1,735.50 | (< 1%) 1.88M to 1.88M | |
| 02-Apr-24 6:32 PM View: | Riley Anthony A Chief Financial Officer | Forte Biosciences, Inc. (FBRX) | 01-Apr-24 | Payment of Exercise | 3,345 | $0.71 | $2,366.59 | (2%) 197.82K to 194.47K | |
| 03-Jan-24 4:02 PM View: | Riley Anthony A Chief Financial Officer | Forte Biosciences, Inc. (FBRX) | 01-Jan-24 | Payment of Exercise | 3,841 | $0.82 | $3,156.15 | (2%) 192.28K to 188.44K | |
| 03-Jan-24 4:04 PM View: | Chen Hubert C See remarks | Forte Biosciences, Inc. (FBRX) | 01-Jan-24 | Option Exercise | 7,500 | -- | -- | 8% 88.98K to 96.48K | |
| 03-Jan-24 4:01 PM View: | Wagner Paul A. See Remarks Director | Forte Biosciences, Inc. (FBRX) | 01-Jan-24 | Option Exercise | 31,250 | -- | -- | 2% 1.82M to 1.85M | |
| 03-Jan-24 4:02 PM View: | Riley Anthony A Chief Financial Officer | Forte Biosciences, Inc. (FBRX) | 01-Jan-24 | Option Exercise | 9,375 | -- | -- | 5% 182.91K to 192.28K | |
| 03-Jan-24 4:04 PM View: | Chen Hubert C See remarks | Forte Biosciences, Inc. (FBRX) | 01-Jan-24 | Payment of Exercise | 3,073 | $0.82 | $2,525.08 | (3%) 96.48K to 93.41K | |
| 03-Jan-24 4:01 PM View: | Wagner Paul A. See Remarks Director | Forte Biosciences, Inc. (FBRX) | 01-Jan-24 | Payment of Exercise | 4,109 | $0.82 | $3,376.37 | (< 1%) 1.85M to 1.85M | |
| 20-Dec-23 10:56 AM View: | Wagner Paul A. See Remarks Director | Forte Biosciences, Inc. (FBRX) | 18-Dec-23 | Private Purchase | 10,000 | $0.75 | $7,525.00 | < 1% 1.81M to 1.82M | |
| 15-Dec-23 6:29 PM View: | Wagner Paul A. See Remarks Director | Forte Biosciences, Inc. (FBRX) | 14-Dec-23 | Purchase | 10,000 | $0.72 | $7,200.00 | < 1% 1.8M to 1.81M | |
| 15-Dec-23 6:29 PM View: | Wagner Paul A. See Remarks Director | Forte Biosciences, Inc. (FBRX) | 13-Dec-23 | Private Purchase | 10,520 | $0.70 | $7,351.38 | < 1% 1.79M to 1.8M | |
| 12-Dec-23 7:30 PM View: | Wagner Paul A. See Remarks Director | Forte Biosciences, Inc. (FBRX) | 12-Dec-23 | Purchase | 4,776 | $0.65 | $3,088.16 | < 1% 1.79M to 1.79M | |
| 12-Dec-23 7:30 PM View: | Wagner Paul A. See Remarks Director | Forte Biosciences, Inc. (FBRX) | 11-Dec-23 | Private Purchase | 25,000 | $0.65 | $16,187.50 | 1% 1.76M to 1.79M | |
| 08-Dec-23 7:20 PM View: | Wagner Paul A. See Remarks Director | Forte Biosciences, Inc. (FBRX) | 08-Dec-23 | Purchase | 15,000 | $0.62 | $9,300.00 | < 1% 1.75M to 1.76M | |
| 08-Dec-23 7:20 PM View: | Wagner Paul A. See Remarks Director | Forte Biosciences, Inc. (FBRX) | 07-Dec-23 | Private Purchase | 36,203 | $0.58 | $21,167.90 | 2% 1.71M to 1.75M | |
| 22-Nov-23 5:51 PM View: | Wagner Paul A. See Remarks Director | Forte Biosciences, Inc. (FBRX) | 22-Nov-23 | Purchase | 400 | $0.43 | $172.00 | < 1% 1.71M to 1.71M | |
| 22-Nov-23 5:51 PM View: | Wagner Paul A. See Remarks Director | Forte Biosciences, Inc. (FBRX) | 20-Nov-23 | Private Purchase | 6,966 | $0.44 | $3,047.89 | < 1% 1.7M to 1.71M | |
| 03-Oct-23 4:27 PM View: | Riley Anthony A Chief Financial Officer | Forte Biosciences, Inc. (FBRX) | 01-Oct-23 | Payment of Exercise | 3,241 | $0.66 | $2,145.54 | (2%) 186.15K to 182.91K | |
| 03-Oct-23 4:29 PM View: | Chen Hubert C See remarks | Forte Biosciences, Inc. (FBRX) | 01-Oct-23 | Option Exercise | 7,500 | -- | -- | 9% 84.07K to 91.57K | |
| 03-Oct-23 4:26 PM View: | Wagner Paul A. See Remarks Director | Forte Biosciences, Inc. (FBRX) | 01-Oct-23 | Option Exercise | 31,250 | -- | -- | 2% 1.68M to 1.71M | |
| 03-Oct-23 4:27 PM View: | Riley Anthony A Chief Financial Officer | Forte Biosciences, Inc. (FBRX) | 01-Oct-23 | Option Exercise | 9,375 | -- | -- | 5% 176.78K to 186.15K | |
| 03-Oct-23 4:29 PM View: | Chen Hubert C See remarks | Forte Biosciences, Inc. (FBRX) | 01-Oct-23 | Payment of Exercise | 2,593 | $0.66 | $1,716.57 | (3%) 91.57K to 88.98K | |
| 03-Oct-23 4:26 PM View: | Wagner Paul A. See Remarks Director | Forte Biosciences, Inc. (FBRX) | 01-Oct-23 | Payment of Exercise | 2,453 | $0.66 | $1,623.89 | (< 1%) 1.71M to 1.7M | |
| 02-Aug-23 6:03 PM View: | Kornfeld Steven Director | Forte Biosciences, Inc. (FBRX) | 31-Jul-23 | Grant | 99,009 | $1.01 | $99,999.10 | 100% 0 to 99.01K | |
| 02-Aug-23 5:58 PM View: | Chen Hubert C See remarks | Forte Biosciences, Inc. (FBRX) | 31-Jul-23 | Grant | 74,257 | $1.01 | $74,999.60 | 757% 9.81K to 84.07K | |
| 02-Aug-23 5:56 PM View: | Wagner Paul A. See Remarks Director | Forte Biosciences, Inc. (FBRX) | 31-Jul-23 | Grant | 247,524 | $1.01 | $249,999.00 | 17% 1.43M to 1.68M | |
| 02-Aug-23 6:02 PM View: | Williams Donald Allen Director | Forte Biosciences, Inc. (FBRX) | 31-Jul-23 | Grant | 59,405 | $1.01 | $59,999.10 | 100% 0 to 59.41K | |
| 02-Aug-23 5:57 PM View: | Riley Anthony A Chief Financial Officer | Forte Biosciences, Inc. (FBRX) | 31-Jul-23 | Grant | 148,514 | $1.01 | $149,999.00 | 525% 28.26K to 176.78K | |
| 02-Aug-23 6:00 PM View: | Gryska David W Director | Forte Biosciences, Inc. (FBRX) | 31-Jul-23 | Grant | 148,514 | $1.01 | $149,999.00 | 100% 0 to 148.51K | |
| 05-Jul-23 4:08 PM View: | Chen Hubert C See remarks | Forte Biosciences, Inc. (FBRX) | 01-Jul-23 | Option Exercise | 7,500 | -- | -- | 153% 4.91K to 12.41K | |
| 05-Jul-23 4:04 PM View: | Wagner Paul A. See Remarks Director | Forte Biosciences, Inc. (FBRX) | 01-Jul-23 | Option Exercise | 31,250 | -- | -- | 2% 1.4M to 1.43M | |
| 05-Jul-23 4:06 PM View: | Riley Anthony A Chief Financial Officer | Forte Biosciences, Inc. (FBRX) | 01-Jul-23 | Option Exercise | 9,375 | -- | -- | 50% 18.63K to 28.0K | |
| 05-Jul-23 4:08 PM View: | Chen Hubert C See remarks | Forte Biosciences, Inc. (FBRX) | 01-Jul-23 | Payment of Exercise | 2,593 | $1.04 | $2,696.72 | (21%) 12.41K to 9.81K | |
| 05-Jul-23 4:04 PM View: | Wagner Paul A. See Remarks Director | Forte Biosciences, Inc. (FBRX) | 01-Jul-23 | Payment of Exercise | 2,453 | $1.04 | $2,551.12 | (< 1%) 1.43M to 1.43M | |
| 05-Jul-23 4:06 PM View: | Riley Anthony A Chief Financial Officer | Forte Biosciences, Inc. (FBRX) | 01-Jul-23 | Payment of Exercise | 3,241 | $1.04 | $3,370.64 | (12%) 28.0K to 24.76K | |
| 04-Apr-23 8:18 PM View: | Riley Anthony A Chief Financial Officer | Forte Biosciences, Inc. (FBRX) | 01-Apr-23 | Option Exercise | 9,375 | -- | -- | 75% 12.49K to 21.87K | |
| 04-Apr-23 8:19 PM View: | Wagner Paul A. See Remarks Director | Forte Biosciences, Inc. (FBRX) | 01-Apr-23 | Option Exercise | 31,250 | -- | -- | 2% 1.38M to 1.41M | |
| 04-Apr-23 8:17 PM View: | Chen Hubert C See remarks | Forte Biosciences, Inc. (FBRX) | 01-Apr-23 | Payment of Exercise | 2,593 | $1.01 | $2,618.93 | (35%) 7.5K to 4.91K | |
| 04-Apr-23 8:18 PM View: | Riley Anthony A Chief Financial Officer | Forte Biosciences, Inc. (FBRX) | 01-Apr-23 | Payment of Exercise | 3,241 | $1.01 | $3,273.41 | (15%) 21.87K to 18.63K | |
| 04-Apr-23 8:17 PM View: | Chen Hubert C See remarks | Forte Biosciences, Inc. (FBRX) | 01-Apr-23 | Option Exercise | 7,500 | -- | -- | 100% 0 to 7.5K | |
| 04-Apr-23 8:19 PM View: | Wagner Paul A. See Remarks Director | Forte Biosciences, Inc. (FBRX) | 01-Apr-23 | Payment of Exercise | 11,046 | $1.01 | $11,156.50 | (< 1%) 1.41M to 1.4M | |
| 19-Dec-22 4:21 PM View: | Wagner Paul A. See Remarks Director | Forte Biosciences, Inc. (FBRX) | 16-Dec-22 | Purchase | 44,024 | $1.07 | $47,000.00 | 3% 1.34M to 1.38M | |
| 19-Dec-22 4:21 PM View: | Wagner Paul A. See Remarks Director | Forte Biosciences, Inc. (FBRX) | 15-Dec-22 | Private Purchase | 55,976 | $1.03 | $57,672.10 | 4% 1.28M to 1.34M | |
| 07-Sep-21 4:09 PM View: | Riley Anthony A Chief Financial Officer | Forte Biosciences, Inc. (FBRX) | 07-Sep-21 | Market Sale | 25,000 | $4.24 | $106,105.00 | (69%) 36.06K to 11.06K | |
| 14-Jan-21 7:17 PM View: | Darcy Thomas E Director | Forte Biosciences, Inc. (FBRX) | 13-Jan-21 | Option Exercise | 500 | $9.59 | $4,793.25 | 2% 26.5K to 27.0K | |
| 30-Jun-20 8:07 PM View: | Riley Anthony A Chief Financial Officer | Forte Biosciences, Inc. (FBRX) | 29-Jun-20 | Market Purchase | 2,000 | $14.11 | $28,220.00 | 6% 34.06K to 36.06K | |
| 30-Jun-20 8:07 PM View: | Riley Anthony A Chief Financial Officer | Forte Biosciences, Inc. (FBRX) | 26-Jun-20 | Market Purchase | 4,700 | $14.52 | $68,225.20 | 16% 29.36K to 34.06K | |
| 29-Jun-20 8:13 PM View: | Wagner Paul A. See Remarks Director 10% Owner | Forte Biosciences, Inc. (FBRX) | 25-Jun-20 | Market Purchase | 7,000 | $14.48 | $101,356.00 | < 1% 2.27M to 2.28M | 4392% |
